Table 1 Patient characteristics
|  | Total (n = 232, %) |
|---|---|
Gender | Â |
 Male | 185 (79.7) |
 Female | 47 (20.3) |
Age | Â |
 ≤ 62 years | 127 (54.7) |
 > 62 years | 105 (45.3) |
ECOG-PS | Â |
 0 | 162 (69.8) |
 1–2 | 70 (30.2) |
Tumor stage* | Â |
 II | 58 (25.0) |
 III + IV | 174 (75.0) |
Tumor location | Â |
 Cervical + upper | 137 (59.1) |
 Middle + lower + multiple | 95 (40.9) |
Length | Â |
 ≤ 5.0 cm | 118 (50.9) |
 > 5.0 cm | 114 (49.1) |
Radiotherapy dose | Â |
 61.2 Gy | 220 (94.8) |
 50.4 ~  < 61.2 Gy | 12 (5.2) |
Chemo regimen | Â |
 PF | 64 (27.6) |
 TF | 102 (44.0) |
 TP | 30 (12.9) |
 TC | 36 (15.5) |
Concurrent chemo completion | Â |
 Yes | 197 (84.9) |
 No | 35 (15.1) |
Consolidation chemo cycles | Â |
 2 cycles | 178 (76.7) |
 0–1 cycle | 54 (23.2) |